Health
Lonza confident of 2020 target for Moderna COVID-19 vaccine supply – Devdiscourse
There is no approved COVID-19 vaccine yet, but several are in advanced trials, including from Pfizer Inc, Johnson & Johnson and Moderna, whose candidate relies …
Lonza is confident that U.S. and Swiss plants it is building to help make Moderna’s COVID-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.
New production lines at Lonza’s site in Portsmouth, New Hampshire, aim to start making vaccine ingredients in November, while three lines in Visp, deep in a valley in the Swiss Alps – to supply 300 million vaccine doses annually – should begin delivering by December. There is no approved…
-
General11 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General24 hours ago‘Brumby Bill’ recognising heritage value of wild horses to be scrapped in NSW
-
Noosa News20 hours agoJane Edmanson hangs up her Gardening Australia hat, reflects on labour of love behind show’s success
-
Business17 hours ago3 of the best ASX ETFs for beginners to buy with $1,000